Monday, July 23, 2007
Novartis CEO Successor May Have Been Selected
According to an article in the Swiss weekly SonntagsZeitung, picked up by Forbes 7/23/07, Novartis AG NVS (NYSE) chief executive Daniel Vasella might propose current Vaccines & Diagnostics chief executive Joerg Reinhardt as his successor.
Labels:
Daniel Vasella,
Forbes,
Joerg Reinhardt,
Novartis AG,
SonntagsZeitung
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment